NucleomeT_no background.png 6


Nucleome Therapeutics Limited


NUCLEOME THERAPEUTICS, a fast-growing biotech start-up that is leveraging a proprietary gene regulation platform, based on a decade of world-leading research from Oxford University, to unlock the non-coding genome for drug target discovery and development. We are seeking a Senior Scientist with expertise in Immunology who is a self-starter, proactive and demonstrates ability to adapt to changing priorities in a fast-past environment of a start-up. The successful candidate will investigate how the non-coding genome regulates different lymphocyte subsets using state of the art genomics approaches (genomics training provided). You will collaborate closely with other experimental and data scientists to guide drug target discovery efforts.